Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics to Provide MDx Testing to Aurora Diagnostics

NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics today announced Aurora Diagnostics has selected it to be the primary partner for molecular testing in Aurora's US network of specialized pathology laboratories.

Aurora will be able to standardize oncology molecular testing services across its 19 labs as a result of the deal, NeoGenomics said.

Ft. Myers, Fla.-based NeoGenomics offers a variety of sequencing-based tests for cancers including metastatic brain cancer, metastatic breast cancer, and acute myeloid leukemia. Among its other tests, it also provides a RT-PCR- and sequencing-based test for analysis of the BCR-ABL1 fusion transcript, which can be used for the qualitative detection of mutations associated with resistance to imatinib and other tyrosine kinase inhibitors.

Financial and other terms of the deal were not disclosed.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.